1268524-70-4

For more than ten years, we have been committed to custom synthesis and mass production of compounds. If you are looking for a supplier or manufacturer of JQ1 (CAS:1268524-70-4), please contact us. We can provide customers with high-quality compounds and good service. Now, we also hope to meet your needs for JQ1 (CAS:1268524-70-4) and other compounds.

Send Inquiry

Product Description

Name	(+)-JQ-1
Synonyms	3mxf;UNII-1MRH0IMX0W;4flp；(S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
Molecular Formula	C₂₃H₂₅ClN₄O₂S
Molecular Weight	456.98800
CAS Number	1268524-70-4
purity	≥98%
Appearance	Off-white solid
Storage conditions	Sealed in dry,2-8°C

Applications：

JQ1(CAS:1268524-70-4) is a thienotriazolodiazepine and a potent inhibitor of the BET family of bromodomain proteins which include BRD2, BRD3, BRD4, and the testis-specific protein BRDT in mammals. BET inhibitors structurally similar to JQ1(CAS:1268524-70-4) are being tested in clinical trials for a variety of cancers including NUT midline carcinoma. It was developed by the James Bradner laboratory at Brigham and Women's Hospital and named after chemist Jun Qi. The chemical structure was inspired by patent of similar BET inhibitors by Mitsubishi Tanabe Pharma [WO/2009/084693]. Structurally it is related to benzodiazepines. While widely used in laboratory applications, JQ1(CAS:1268524-70-4) is not itself being used in human clinical trials because it has a short half life.

Hot Tags: